Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978.Â
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978.Â
Hikma Pharmaceuticals Plc with ticker (LON:HIK) now has a potential upside of 22.2% according to RBC Capital Markets.RBC Capital Markets...
Hikma Pharmaceuticals PLC (LON:HIK) has announced that Siggi Olafsson has resigned as Chief Executive Officer, and from Hikma’s Board of...
Hikma Pharmaceuticals PLC (LON:HIK), the multinational pharmaceutical company, has reported its interim results for the six months ended 30 June...
Hikma Pharmaceuticals PLC (LON:HIK), the multinational pharmaceutical company, has announced the approval of KLOXXADOTM (naloxone hydrochloride) nasal spray 8mg, by...
Hikma Pharmaceuticals PLC (LON:HIK), the multinational pharmaceutical company, has announced that it has resumed the launch of its generic version...
Hikma Pharmaceuticals PLC (LON:HIK), the multinational pharmaceutical company, has reported its interim results for the six months ended 30 June...
Data policy – All information should be used for indicative purposes only. You should independently check data before making any investment decision and or seek professional advice. DirectorsTalk cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.